Karyopharm Therapeutics
KPTI
KPTI
77 hedge funds and large institutions have $187M invested in Karyopharm Therapeutics in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
77
Holding in Top 10
1
Calls
$803K
Puts
$221K
Top Buyers
| 1 | +$9.78M | |
| 2 | +$562K | |
| 3 | +$382K | |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$221K |
| 5 |
State Street
Boston,
Massachusetts
|
+$177K |
Top Sellers
| 1 | -$7.89M | |
| 2 | -$2.02M | |
| 3 | -$1.06M | |
| 4 |
D.E. Shaw & Co
New York
|
-$632K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$630K |